Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Stopped 19 patients screenfailed, stopping recruitment before first patient enrollment to analyze pilot results from screening samples.

Conditions

• Ovarian Endometrioid Tumor
• Fallopian Tube Cancer
• Primary Peritoneal Cancer
• TP53 Mutation

Interventions

• DRUG: Atezolizumab
• DRUG: Bevacizumab

Sponsor

University Health Network, Toronto